title: The clinical value of tissue factor assays.
abstract: Tissue factor (TF) is now considered to be the primary physiologic activator of the blood coagulation system. Coupled with recent advances in our understanding of the biochemistry of TF this has heightened interest in measuring aspects of TF activity in disease states. Expression of TF by blood monocytes in various diseases is an established trigger for intravascular coagulation and there is now a considerable body of experience with its measurement. This has considerable clinical potential although more widespread application awaits a consensus on the most appropriate methodologic approach to its measurement. TF can be detected in urine and may reflect the activation state of renal macrophages. Urinary TF is increased in cancer and could have diagnostic and prognostic value in a variety of malignant diseases. Finally, it is now possible to measure soluble TF in plasma. One such assay is commercially available and is technically simple to perform. The clinical value of such assays, however, must await better understanding of the source and function of soluble TF in plasma.
authors.affiliation: Hemostasis and Thrombosis Research Unit, Walt Disney Memorial Cancer Institute, Florida Hospital, Altamonte Springs 32701, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Francis
authors.forename: M
authors.initials: M
authors.lastname: Carvalho
authors.forename: D A
authors.initials: DA
authors.lastname: Francis
mesh_terms: D001777:Blood Coagulation; D004211:Disseminated Intravascular Coagulation / Q000097:blood; D006801:Humans; D009000:Monocytes / Q000378:metabolism; D013925:Thromboplastin / Q000032:analysis* / Q000378:metabolism / Q000652:urine
chemical_list: D013925:Thromboplastin